Trial Profile
Safety Confirmation Study of LY231514 [pemetrexed] Plus Cisplatin in Patients With Malignant Pleural Mesothelioma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Aug 2009
Price :
$35
*
At a glance
- Drugs Pemetrexed (Primary) ; Cisplatin
- Indications Malignant-mesothelioma
- Focus Adverse reactions
- Sponsors Eli Lilly and Company
- 10 Apr 2007 Status changed from in progress to completed.
- 15 Mar 2007 New trial record.